AngioDynamics to study NanoKnife in pancreatic cancer - 0 views
-
jacob logan on 03 Apr 19AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) application of its NanoKnife System in the treatment of stage III pancreatic cancer.